STATE STREET CORP, a registered investment adviser, initiated a new position in AbbVie Inc. (NYSE:ABBV) during Q4 2025, according to its most recent 13F filing with the Securities…
STATE STREET CORP, a registered investment adviser, initiated a new position in AbbVie Inc. (NYSE:ABBV) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 80,940,931 shares of the Healthcare company, valued at approximately $18.5B as of the filing date.
AbbVie Inc.'s stock currently trades at $229.69 with a market capitalization of $395.7B.
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Current market data
NYSE · ABBV
$263.96
Down: -$0.24 · -0.09%
Live quote updated
Keep reading
